Global Cooperation Necessary To Eliminate Drug-Resistant Malaria In Mekong Region, Prevent Spread To Other Regions

New York Times: Taking the Battle Against Malaria to the Mekong
Christopher Plowe, director of the Institute for Global Health at the University of Maryland School of Medicine

“…[W]ith coordination, hard work, and proper funding, we can achieve our goal [of eliminating malaria from the Mekong region]. … Eliminating multidrug-resistant malaria from the Mekong before it spreads to Africa will require so-called elimination accelerators, including highly sensitive new tests to identify symptom-free carriers of malaria infection, and mass drug treatment of infected groups or populations. We also need closer cooperation from American and European health officials, international health agencies and financiers, local nongovernmental organizations, and especially from the inhabitants and governments of the Mekong region. We must ramp up quickly; drug resistance is spreading; if it spins out of control, we run the risk of a huge resurgence of malaria in other parts of Asia and especially in Africa” (9/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.